The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), RTX Corporation (RTX) and Regeneron Pharmaceuticals, Inc. (REGN), as well as a micro-cap s...
Goldman Sachs Research European Economics Analyst: 10 Questions for 2025 Jan 10, 2025 Top of Mind 2024: 4 Themes in Charts Dec 19, 2024 Climate Transition GS SUSTAIN: AI/data centers' global power surge: The push for the 'Green' data center ...
[182] On July 15, 2003, Goldman Sachs, Lehman Brothers and Morgan Stanley were sued for artificially inflating the stock price of RSL Communications by issuing untrue or materially misleading statements in research analyst reports, and paid $3,380,000 (~$5.37 million in 2023) for settlement.[...
Reports on the decreased stock ratings for four regional banks in the United States given by Goldman, Sachs & Co. analyst Lori Appelbaum. Influence of the year-long rally in the regional banking sector on the downgrades according to Appelbaum; Rates given to North Fork Bancorp., First Midwest...
Fintel reports that on January 30, 2025, Goldman Sachs upgraded theiroutlookfor RH (NYSE:RH) fromSelltoNeutral. Analyst Price Forecast Suggests 10.84% Upside As of January 29, 2025, the average one-yearprice targetfor RH is $467.74/share. The forecasts range from a low of $263.61 to a ...
显然,从最初级的 Analyst 成长为 MD 需要很长一段时间,根据 2013年Goldman Sachs 的 MDs 人才库数据显示,晋升到 MD 平均需要花费12.1 年。 或许你会被这个时间吓到,但其实,这几乎已经是九大投行中最快的晋升速度了。要知道,J.P. Morgan 的 MD 晋升之路平均约为 16 年。
Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering "gene therapy" treatment: cures could be bad for business in the long run. "Is curing patients a sustainable business model?" analysts ask in an April 10 report entitled...
Goldman Sachs Research European Economics Analyst: 10 Questions for 2025 Jan 10, 2025 Goldman Sachs Research Equity Outlook 2025: The Year of the Alpha Bet Dec 02, 2024 Top of MindAllison Nathan of Goldman Sachs Research dives into macro developments that are top of mind for investors, executiv...
Analyst Report FA Report PDF The Goldman Sachs Access Investment Grade Corporate Bond ETF (GIGB) is Goldman’s offering for investors looking to access a corner of the bond market that should be a core component of any-long term, buy-and-hold portfolio. GIGB tracks the proprietary FTSE Gold...
Analyst Report FA Report PDF The Goldman Sachs Access Ultra Short Bond ETF (GSST) is Goldman’s answer to the hugely successful ETF launched by its competitors at JPMorgan. Like the JPMorgan Ultra-Short Income ETF (JPST), GSST is an actively-managed fund that invests in short-term investm...